arrow_back Trending Legislation
Share share

Extending National Security Commission on Emerging Biotechnology Operations

This law extends the operation of the federal commission analyzing how modern biotechnology affects U.S. national security. These changes grant the commission more time to prepare reports and recommendations, which is crucial for protecting the country against biological threats and maintaining technological advantage. Citizens benefit indirectly from the government being better prepared for challenges related to new medical and biological technologies.
Key points
The deadline for the Biotechnology Commission's operation is extended to December 31, 2026, ensuring continuity in national security work.
The Commission's functioning is streamlined by validating delayed member appointments, preventing decision-making paralysis.
The Commission receives an additional 6 months to submit its final report on the impact of biotechnology on national security.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
BioTech Innovation and National Security Continuation Act
Print number: HR 9900
Sponsor: Rep. Khanna, Ro [D-CA-17]
Process start date: 2024-10-01
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Extending National Security Commission on Emerging Biotechnology Operations

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 9900.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-10-01.

What are the main provisions?

Key points include:

  • The deadline for the Biotechnology Commission's operation is extended to December 31, 2026, ensuring continuity in national security work.
  • The Commission's functioning is streamlined by validating delayed member appointments, preventing decision-making paralysis.
  • The Commission receives an additional 6 months to submit its final report on the impact of biotechnology on national security.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Khanna, Ro [D-CA-17].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Armed Services.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of HR 9900

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Security Health